Quectel Expands Mid-tier 5G Portfolio with New RedCap 3GPP Release 17 Variants
2.3.2026 08:00:00 CET | Business Wire | Press Release
Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the expansion of its 5G RedCap portfolio with the launch of the RM255C-GL for global markets and the RG255C-NA for the North America market, further strengthening its mid-tier 5G offering for worldwide deployments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260301754857/en/
Quectel expands mid-tier 5G portfolio with new RedCap 3GPP release 17 variants
As 5G expands further into industrial and IoT domains, the need for solutions that combine strong performance with cost efficiency is becoming increasingly critical. Positioned between high-speed eMBB and narrowband NB-IoT, 5G RedCap (Reduced Capability) has emerged as the ideal technology to address this mid-tier connectivity gap. With a comprehensive product portfolio and global deployment expertise, Quectel enables a seamless transition for mid-speed IoT applications moving toward scalable 5G connectivity.
The RM255C-GL is a 5G Sub-6GHz RedCap module in the M.2 form factor, developed in accordance with 3GPP Release 17. It supports peak data rates of up to 223Mbps downlink and 123Mbps uplink, with 5G Sub-6GHz standalone (SA) operation and LTE Cat 4 fallback. Backward compatibility with Release 15 and Release 16 networks ensures smooth deployment across existing infrastructures. Designed for seamless upgrades, the RM255C-GL is pin-to-pin compatible with Quectel’s RM5x0N and RM50xQ 5G series, and both pin-to-pin and size compatible with selected LTE-A and 4G modules including the EM06, EM12 series, EM160R-GL and EM05, simplifying migration from LTE to 5G RedCap.
The module integrates Qualcomm® IZat™ Gen 9VT location technology with optional multi-constellation GNSS support (GPS, GLONASS, BDS, Galileo, QZSS and NavIC), enabling fast, accurate and reliable positioning. With worldwide 5G and LTE coverage, support for 5G SA mode, embedded protocol stacks and high-speed USB 2.0 and PCIe 2.0 interfaces, the RM255C-GL is well suited to a broad range of mid-tier IoT applications.
The RG255C-NA is a 5G RedCap Sub-6GHz LGA module designed in compliance with 3GPP Release 17. Supporting key 5G capabilities including URLLC and network slicing, the module delivers peak data rates of up to 223Mbps downlink and 123Mbps uplink. It operates in 5G Sub-6GHz standalone (SA) mode with LTE Cat 4 fallback and is backward compatible with Release 15 and Release 16 networks, ensuring smooth migration and broad network coverage. Compatible with Quectel’s compact EG2x 4G module series, the RG255C-NA simplifies design upgrades while meeting mid-speed application requirements for higher capacity, low latency, and enhanced reliability in industrial and commercial deployments.
Purpose-built for industrial-grade applications, the RG255C-NA integrates Qualcomm® IZat™ Gen 9VT location technology, supporting multi-constellation GNSS including GPS, GLONASS, NavIC, BDS, QZSS and Galileo. The integrated GNSS receiver streamlines product development while enabling fast, accurate, and dependable positioning. A comprehensive suite of Internet protocols, industry-standard interfaces, including USB 2.0, PCIe 2.0, PCM, UART, SGMII and SPI, along with USB driver support for Windows 10/11, Linux and Android, ensures broad compatibility and flexibility across a wide range of 5G RedCap IoT applications.
"The commercialization of 5G RedCap is a key milestone in making 5G ubiquitous. For a long time, the industry has faced difficult trade-offs between performance and cost. The launch of Quectel's two new RedCap modules aims to solve this core pain point,” commented Leo Yao, Product Director, Quectel Wireless Solutions. “Quectel offers not just a module, but a complete solution including hardware reference designs for application scenarios, external edge computing capabilities, and global certifications, significantly lowering customers' product development barriers and time-to-market."
As 5G adoption accelerates beyond consumer markets into industrial applications, demand is growing for solutions that balance performance with cost and power efficiency. In mid- to high-speed use cases such as Industrial IoT, video surveillance, and wearables, traditional 5G modules can be oversized in cost, power consumption, and form factor, while 4G technologies lack the bandwidth, latency, and long-term roadmap required for future deployments, particularly as LTE sunset plans advance in markets such as the United States. Defined in the 3GPP Release 17 standard, 5G RedCap addresses this gap by streamlining device capabilities to significantly reduce complexity, cost, and energy consumption, while retaining essential 5G features. Positioned between LTE Cat 4/6 and full 5G, RedCap is set to become a key enabler of scalable, industrial-grade 5G adoption.
Across sectors such as energy, mobile broadband, and wearables, 5G RedCap is overcoming the cost and power limitations associated with traditional 5G modules, delivering right-sized connectivity to support large-scale digital transformation. RedCap is well suited to smart grid deployments, delivering the ultra-reliable, low-latency performance utilities require while reducing module complexity and cost. In mobile hotspots and industrial sensor networks, it enables scalable, cost-efficient 5G connectivity, ideal for smart factories with large numbers of connected devices. For wearables such as smartwatches and fitness trackers, RedCap lowers power consumption and module size, supporting compact designs and extended battery life while bringing 5G to next-generation consumer and professional devices.
The RM255C-GL and RG255C-NA have successfully completed the required regulatory and industry conformance certifications, reinforcing their readiness for global deployment. The RG255C-NA is certified to FCC, IC and PTCRB standards, while the RM255C-GL has achieved CE, RCM, FCC, IC, GCF and PTCRB certifications. This comprehensive approval coverage streamlines device certification, reduces time to market and provides customers with confidence in seamless, compliant integration across target regions.
About Quectel
Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global end-to-end IoT solutions provider backed by outstanding support and services.
With a worldwide team of over 5,800 professionals, we lead the way in delivering end-to-end IoT solutions, spanning cellular, GNSS, satellite, Wi-Fi and Bluetooth modules, high-performance antennas, value-added services and full turnkey offerings including ODM services and system integration.
With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.
For more information, please visit www.quectel.com or LinkedIn
View source version on businesswire.com: https://www.businesswire.com/news/home/20260301754857/en/
Contacts
Media contact: media@quectel.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release
Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom